The US Food and Drug Administration will work with Syapse Inc. to develop new real-world evidence sources outside electronic health records for various regulatory purposes.
FDA's Oncology Center of Excellence and Syapse announced a new four-year partnership on 14 August for real-world evidence (RWE) development...